வழக்கம் போன்று பொறுப்பற்ற முறையில் தமிழ் ஊடகம், முக்கியமாக தினக்குரல் செய்தியைத் திரித்து வெளியிட்டுள்ளது.
அஸ்ராசெனிகா உலகளவில் கொவிட் தடுப்பூசிக்கான தேவை குறைவடைந்து செல்வதனாலும், சந்தையில் வேறு பல கொவிட் தடுப்பூசிகள் இருப்பதனாலும், தன் தடுப்பூசியை திரும்பப் பெறுவதுடன், தயாரிப்பதையும்
நிறுத்துவதாகவே அறிவித்துள்ளது. தன் தடுப்பூசியால் பக்கவிளைவுகள் ஏற்படுவதால், திரும்பப் பெறுவதாக அந் நிறுவனம்அறிவிக்கவில்லை.
மேலும்:
May 7 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-withdraw-covid-vaccine-worldwide-telegraph-reports-2024-05-07/
LondonCNN —
AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand.
The vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been one of the main Covid-19 vaccines worldwide, with more than 3 billion doses supplied since the first was administered in the United Kingdom on January 4, 2021.
But the vaccine has not generated revenue for AstraZeneca since April 2023, the company said.
https://www.cnn.com/2024/05/08/business/astrazeneca-covid-vaccine-withdrawal/index.html
https://www.bbc.com/news/health-68977026